吡格列酮抗炎作用对代谢综合征患者胰岛素敏感性、血管内皮细胞功能的影响

卢辉和, 黎叶飞, 盛臻强, 王毅

卢辉和, 黎叶飞, 盛臻强, 王毅. 吡格列酮抗炎作用对代谢综合征患者胰岛素敏感性、血管内皮细胞功能的影响[J]. 实用临床医药杂志, 2012, (19): 38-39,42.
引用本文: 卢辉和, 黎叶飞, 盛臻强, 王毅. 吡格列酮抗炎作用对代谢综合征患者胰岛素敏感性、血管内皮细胞功能的影响[J]. 实用临床医药杂志, 2012, (19): 38-39,42.
LU Huihe, LI Yefei, SHENG Zhenqiang, WANG Yi. Anti-inflammatory effect of pioglitazone on insulin sensitivity and vascular endothelial cell function of patients with metabolic syndrome[J]. Journal of Clinical Medicine in Practice, 2012, (19): 38-39,42.
Citation: LU Huihe, LI Yefei, SHENG Zhenqiang, WANG Yi. Anti-inflammatory effect of pioglitazone on insulin sensitivity and vascular endothelial cell function of patients with metabolic syndrome[J]. Journal of Clinical Medicine in Practice, 2012, (19): 38-39,42.

吡格列酮抗炎作用对代谢综合征患者胰岛素敏感性、血管内皮细胞功能的影响

详细信息
  • 中图分类号: R587.1

Anti-inflammatory effect of pioglitazone on insulin sensitivity and vascular endothelial cell function of patients with metabolic syndrome

  • 摘要: 目的 研究吡格列酮对伴糖耐量减低(IGT)的代谢综合征(MS)患者血管内皮细胞功能的影响.方法 对30例伴IGT的MS患者采用吡格列酮45 mg/d治疗8周.在治疗前后分别测定胰岛素敏感度检测指数(QU ICKI)、肱动脉内皮依赖性舒张功能(FMD)和硝酸甘油诱导的非内皮依赖性舒张功能(NID),高敏C反应蛋白(hs-CRP)改变.结果 治疗后FMD明显改善(P<0.01),QUICKI指数升高(P<0.05); hs-CRP水平降低(P<0.01).结论 吡格列酮能明显改善IGT的MS患者的血管内皮细胞功能,其机制可能与改善体内胰岛素抵抗,抑制慢性炎症反应有关.
  • Hirohito Sone, Sachiko Tanaka, Shun Ishibashi. The New Worldwide Definition of Metabolic Syndrome Is Not a Better Diagnostic Predictor of Cardiovascular Disease in Japanese Diabetic Patients Than the Existing Definitions Additional analysis from the Japan Diabetes Complications Study [J]. Diabetes Care January, 2006(1):145.
    Campia U, Matuskey LA, Panza JA. Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors [J]. Circulation, 2006(6):867.
    Santo-Tomas M, Lopez Jimenez F, Machado H. Effect of cigar smoking on endothelium-dependent brachial artery dilation in healthy young adults [J]. American Heart Journal, 2002(1):83.
    Bahijri SM, Alissa EM, Akbar DH. Estimation of insulin resistance in non-diabetic normotensive Saudi adults by QUICKI, HOMA-IR and modified QUICKI:a comparative study [J]. Annals of Saudi Medicine, 2010(4):257.
    Bai X, Wang X, Xu Q. Endothelial damage and stem cell repair in atherosclerosis [J]. Vascular Pharmacology, 2010, (5-6):224.
    de Souza CJ, Eckhardt M, Gagen K. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance [J]. Diabetes, 2001(8):1863.
    Muntoni S. Insulin resistance:pathophysiology and rationale for treatment [J]. Annals of Nutrition and Metabolism, 2011(1):25.
    Paoletti R, Bolego C, Poli A. Metabolic syndrome, inflammation and atherosclerosis [J]. Vasc Health Risk Manag, 2006(2):145.
    Gensini GF, Cori AM, Dilaghi B. Effect of atorvastatin on circulating hsCRP concentrations:A sub-study of the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study [J]. International Journal of Cardiology, 2010(3):257.
计量
  • 文章访问数:  96
  • HTML全文浏览量:  27
  • PDF下载量:  11
  • 被引次数: 0
出版历程
  • 发布日期:  2013-01-15

目录

    /

    返回文章
    返回
    x 关闭 永久关闭